David Jin
2023 - Fortress Biotech
In 2023, David Jin earned a total compensation of $1.3M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech, a 15% decrease compared to previous year.
Compensation breakdown
| Option Awards | $582,500 |
|---|---|
| Salary | $400,000 |
| Stock Awards | $330,400 |
| Other | $7,333 |
| Total | $1,320,233 |
Jin received $582.5K in option awards, accounting for 44% of the total pay in 2023.
Jin also received $400K in salary, $330.4K in stock awards and $7.3K in other compensation.
Rankings
In 2023, David Jin's compensation ranked 889th out of 2,785 executives tracked by ExecPay. In other words, Jin earned more than 68.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 889 out of 2,785 | 68th |
Division Manufacturing | 526 out of 1,525 | 66th |
Major group Chemicals And Allied Products | 357 out of 864 | 59th |
Industry group Drugs | 346 out of 827 | 58th |
Industry Pharmaceutical Preparations | 235 out of 592 | 60th |
Source: SEC filing on April 5, 2024.
Jin's colleagues
We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2023.
News
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2023 pay stays at $350K
August 28, 2024
AVENUE THERAPEUTICS CEO Alexandra MacLean's 2023 pay jumps 304% to $1.2M
May 3, 2024
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019